Sort publications on year

  • Pharmaco - Epidemiology

    The SCOPE Study : Healthcare consumption related to patients with Chronic Obstructive Pulmonary Disease in France

    DETOURNAY B, PRIBIL C, FOURNIER M, HOUSSET B, HUCHON G, HUAS D, GODARD P, VOINET C, CHANAL I, JOURDANNE C, DURAND-ZALESKI I, the SCOPE Group

    Value Health ; 7(2):168-174

  • Pharmaco - Epidemiology

    The psychological impact of terrorism : an epidemiologic study of posttraumatic stress disorder and associated factors in victims of the 1995-1996 bombings in France

    VERGER P, DAB W, LAMPING DL, LOZE JY, DESCHASEAUX-VOINET C, ABENHAIM L, ROUILLON F

    Am J Psychiatry ; 161(8):1384-1389

  • Pharmaco - Epidemiology

    Medical outcomes of glaucoma therapy from a Nationwide representative survey

    DENIS P, LAFUMA A, BERDEAUX G

    Clin Drug Investig ; 24(6):343-352

  • Pharmaco - Epidemiology

    EPIGRAM, étude phamacoépidémiologique de l’obésité : méthodologie et critères de qualité

    VRAY M, JOUBERT JM, ESCHWÈGE E, LIARD F, FAGNANI F, COMMENGES B, STEINBERG G, BÉGAUD B

    Thérapie ; 59(6):573-579

  • Pharmaco - Epidemiology

    Costs of rheumatoid arthritis in France : a multicenter study of 1109 patients managed by hospital-based rheumatologists

    GUILLEMIN F, DURIEUX S, DAURES JP, LAFUMA A, SARAUX A, SIBILIA J, BOURGEOIS P, SANY J

    J Rheumatol ; 31(7):1297-1304

  • Pharmaco - Epidemiology

    Comparison of Nd : YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, or acrylic intra-ocular lenses in four European countries

    AUFFARTH G, BRÉZIN A, CAPOROSSI A, LAFUMA A, MENDICUTE J, BERDEAUX G, SMITH A

    Ophthalmic Epidemiol ; 11(4):319-329

  • Pharmaco - Epidemiology

    Characteristics of patients with rheumatoid arthritis in France : a study of 1109 patients managed by hospital based rhumatologists

    SANY J, BOURGEOIS P, SARAUX A, DURIEUX S, LAFUMA A, DAURES JP, GUILLEMIN F, SIBILIA J

    Ann Rheum Dis ; 63(10):1235-1240

  • Pharmaco - Epidemiology

    Blindness, low vision, and other handicaps as risk factors attached to institutional residence

    BREZIN A,LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G

    Br J Ophtalmol ; 88(10):1330-1337

  • Pharmaco - Epidemiology

    An epidemiological model of genital herpes : application to France

    BOELLE PY, DETOURNAY B, VALLERON PJ, FAGNANI F, HALIOUA B, NICOLAS JC

    Ann Dermatol Venereol ; 131(1 Pt 1):17-26

  • Pharmaco - Epidemiology

    A population-based study of diabetes and its characteristics during the fasting month of ramadan in 13 countries

    SALTI I, BÉNARD E, DETOURNAY B, BIANCHI-BISCAY M, LE BRIGAND C, VOINET C, JABBAR A

    Diabetes Care ; 27(10):2306-2311

  • Pharmaco - Epidemiology

    A multicenter pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999

    LORTHOLARY O, CHARLEMAGNE A, BASTIDES F, CHEVALIER P, DATRY A, GONZALVES MF, MICHEL G, TILLEUL P, VEBER B, HERBRECHT R

    J Antimicrob Chemother ; 54(2):456-64

  • Pharmaco - Epidemiology

    Health related quality of life in patients with community-acquired pneumococcal pneumonia in France.

    ANDRADE LF, SABA G, RICARD JD, MESSIKA J, GAILLAT J, BONNIN P, CHIDIAC C, ILLES HG, LAURICHESSE H, DETOURNAY B, PETITPRETZ P, DE POUVOURVILLE G.

    Health Qual Life Outcomes ; 2018;16 (1):28

  • Pharmaco - Epidemiology

    L’évaluation risque/bénéfice dans les domaines de la santé et de l’environnement : similitudes et différences

    FAGNANI F

    Environnement Risques & Santé ; 1(3):1-3

  • Pharmaco - Epidemiology

    Prise de position de la Société Francophone du Diabète (SFD) sur la prise en charge médicamenteuse de l’hyperglycémie du patient diabétique de type 2.

    DARMON P, BAUDUCEAU B, BORDIER L, BRINGER J, CHABRIER G, CHARBONNEL B, DETOURNAY B, FONTAINE P, GRIMALDI A, GOURDY P, GUERCI B, PENFORNIS A, RIVELINE JP, SCHEEN A.

    Med Mal Metab ; 2017;11(6):577-593

  • Pharmaco - Epidemiology

    DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial

    JEANDIDIER N, CHAILLOUS L, FRANC S, BENHAMOU PY, SCHAEPELYNCK P, HANAIRE H, CATARGI B, FARRET A, FONTAINE P, GUERCI B, REZNIK Y, PENFORNIS A, BOROT S, SERUSCLAT P, KHERBACHI Y, D’ORSAY G, DETOURNAY B, SIMON P, CHARPENTIER G

    JMIR Res Protoc ; 2018;7 (4)